TEACO: Taxotere, Eloxatin, Avastin in Cancer of the Ovary

NCT00296816 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

132

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer

Interventions

DRUG: Bevacizumab (Avastin®)
DRUG: Docetaxel (Taxotere®)
DRUG: Oxaliplatin (Eloxatin®)

Sponsor

Sanofi